AMRITA VISHWA VIDYAPEETHAM

Caring Cross Partners with Amrita Research Center to Develop Affordable CAR-T and Gene Therapies for Underserved Indian Populations

- Caring Cross, a U.S.-based non-profit, has announced a strategic partnership with Amrita Research Center Delhi to develop affordable cell and gene therapies targeting sickle cell disease, thalassemia, and various cancers in India's underserved communities. - The collaboration will establish decentralized therapeutic manufacturing to reduce costs and advance TriCAR-T cell therapies for leukemia and lymphoma treatment at the point of care. - This partnership addresses the critical need for accessible advanced therapies in India, a country with 1.4 billion people facing substantial burden of hereditary blood disorders and cancers affecting lower-income populations. - The initiative aligns with India's national public health priorities and aims to create a global model for equitable advanced therapy solutions.